Literature DB >> 26677256

Clinical and Molecular Characterization of Invasive Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Infections in Korean Hospitals.

Eu Suk Kim1, In-Gyu Bae2, Jeong Eun Cho3, Yun Jung Choi3, Il-Hwan Kim4, Gi-Su Kang4, Hye-yun Sin3, Kyoung-Ho Song1, Chulmin Park5, Dong-Gun Lee6, Moonsuk Kim1, Kyoung Un Park7, Hong Bin Kim8.   

Abstract

Invasive heteroresistant vancomycin-intermediate Staphylococcus aureus (h-VISA) isolates were identified and characterized in 10 Korean hospitals from July 2009 to June 2011. The prevalence of h-VISA infections was 3.3% (42/1,289). Most (41/42) were health care-associated infections caused by strains belonging to sequence type 5. Cases of persistent bacteremia were frequent (17/42), and 30-day mortality was high (16/40).
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26677256      PMCID： PMC4767959          DOI： 10.1128/JCM.02595-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.

Authors:  K Hiramatsu; N Aritaka; H Hanaki; S Kawasaki; Y Hosoda; S Hori; Y Fukuchi; I Kobayashi
Journal:  Lancet       Date:  1997-12-06       Impact factor: 79.321

2.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

Review 3.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

4.  Molecular characterization of methicillin-resistant Staphylococcus aureus isolates in Korea.

Authors:  Eu Suk Kim; Hye Jin Lee; Gyung-Tae Chung; Yeong-Seon Lee; Dong-Hyeon Shin; Sook-In Jung; Kyoung-Ho Song; Wan-Beom Park; Nam Joong Kim; Kyoung Un Park; Eui-Chong Kim; Myoung-Don Oh; Hong Bin Kim
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

5.  A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital.

Authors:  M Wootton; R A Howe; R Hillman; T R Walsh; P M Bennett; A P MacGowan
Journal:  J Antimicrob Chemother       Date:  2001-04       Impact factor: 5.790

6.  Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides.

Authors:  T R Walsh; A Bolmström; A Qwärnström; P Ho; M Wootton; R A Howe; A P MacGowan; D Diekema
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

7.  Clinical and laboratory characteristics of invasive infections due to methicillin-resistant Staphylococcus aureus isolates demonstrating a vancomycin MIC of 2 micrograms per milliliter: lack of effect of heteroresistant vancomycin-intermediate S. aureus phenotype.

Authors:  S W Satola; F C Lessa; S M Ray; S N Bulens; R Lynfield; W Schaffner; G Dumyati; J Nadle; J B Patel
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

8.  Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.

Authors:  Patrick G P Charles; Peter B Ward; Paul D R Johnson; Benjamin P Howden; M Lindsay Grayson
Journal:  Clin Infect Dis       Date:  2004-01-12       Impact factor: 9.079

9.  Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus.

Authors:  M C Enright; N P Day; C E Davies; S J Peacock; B G Spratt
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

10.  Characteristics of invasive Staphylococcus aureus infections in three regions of Korea, 2009-2011: a multi-center cohort study.

Authors:  Kyoung-Ho Song; Eu Suk Kim; Hye-Yun Sin; Kyung-Hwa Park; Sook-In Jung; Nara Yoon; Dong-Min Kim; Chang Seop Lee; Hee-Chang Jang; Yoonseon Park; Kkot Sil Lee; Yee Gyung Kwak; Jae Hoon Lee; Seong Yeon Park; Minkyo Song; Sue K Park; Yeong-Seon Lee; Hong Bin Kim
Journal:  BMC Infect Dis       Date:  2013-12-10       Impact factor: 3.090
View more
  4 in total

1.  agr functionality affects clinical outcomes in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia.

Authors:  C K Kang; Y K Kim; S-I Jung; W B Park; K-H Song; K-H Park; P G Choe; H-C Jang; S Lee; Y-S Kim; Y G Kwak; K T Kwon; S Kiem; C-J Kim; E S Kim; H B Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-06-21       Impact factor: 3.267

2.  Nemonoxacin Enhances Antibacterial Activity and Anti-Resistance Mutation Ability of Vancomycin against Methicillin-Resistant Staphylococcus aureus in an In Vitro Dynamic Pharmacokinetic/Pharmacodynamic Model.

Authors:  Junchen Huang; Siwei Guo; Xin Li; Fang Yuan; You Li; Bing Xu; Junyuan Gu; Yong Qiao
Journal:  Antimicrob Agents Chemother       Date:  2021-12-13       Impact factor: 5.938

3.  Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis.

Authors:  Aref Shariati; Masoud Dadashi; Majid Taati Moghadam; Alex van Belkum; Somayeh Yaslianifard; Davood Darban-Sarokhalil
Journal:  Sci Rep       Date:  2020-07-29       Impact factor: 4.379

4.  Genetic Factors Associated with Increased Host Defense Antimicrobial Peptide Resistance in Sequence Type 5 Healthcare-Associated MRSA Clinical Isolates.

Authors:  Kyoung-Mi Kang; Gi Yong Lee; Soo-Jin Yang
Journal:  Biomolecules       Date:  2020-10-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.